Provectus expands compassionate use for PV-10November 3rd 2009
National report - Provectus Pharmaceuticals has expanded its compassionate use program for PV-10, which is being developed as a therapeutic agent for metastatic melanoma and other cancers, making it available for select cancer patients in the United States, according to a press release.
ASDS recognizes Dr. Neil Sadick for excellence in educationNovember 3rd 2009
Phoenix - The American Society for Dermatologic Surgery (ASDS) presented Neil Sadick, M.D., with the Excellence in Education Award for his "significant commitment time and energy to teach dermatologic surgery and promote the advancement of the specialty," according to Robert Weiss, M.D., president of ASDS.
FDA approves Stelara for treatment of psoriasisOctober 6th 2009
Horsham, Pa. ? The U.S. Food and Drug Administration (FDA) has approved the biologic Stelara (ustekinumab, Centocor Ortho Biotech) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, according to a Centocor press release.
Spain withdraws cervical cancer shotMarch 3rd 2009
Madrid ? Spanish authorities withdrew 76,000 doses of Gardasil (human papillomavirus quadrivalent vaccine, recombinant, Merck) from the market in February after two teenagers who received the vaccine were hospitalized, according to the news agency Agence France-Presse.
Shorter interferon course adequately treats melanomaFebruary 3rd 2009
New York - Treating patients with resected high-risk melanoma with either one month or one year of adjuvant high-dose interferon alpha-2b therapy does not significantly change relapse-free or overall survival, cancerpage.com reports.
AMA sets standards for physician self-referralDecember 2nd 2008
Orlando ? The American Medical Association?s Council on Ethical and Judicial Affairs (CEJA) has concluded that it is unethical for physicians to self-refer to facilities where they have a financial stake unless they disclose that information to all their patients, Medpage Today reports.
Acne cream recalled from Wal-Mart, Kroger, Dollar GeneralDecember 2nd 2008
National report ? CSI, USA has issued a recall for all 1 ounce tubes of 10 percent benzoyl peroxide acne cream, which were sold under different names at Kroger, Wal-Mart and Dollar General, due to possible contamination with Burkholderia Cepacia bacteria, AboutLawsuits.com reports.
FDA approves Acanya Gel for the treatment of acneDecember 2nd 2008
Redwood City, Calif. ? Arcutis Pharmaceuticals announces the Food and Drug Administration (FDA) approval of Acanya Gel (clindamycin phosphate 1.2 percent and benzoyl peroxide 2.5 percent) for the once-daily treatment of acne vulgaris in patients 12 years and older, according to BusinessWire.
Study shows why some tumors spreadDecember 2nd 2008
Short Headline: Why tumors spread Chicago ? Researchers have found that when a fragment of ribonucleic acid, microRNA-101, is missing, a protein called EZH2 starts to proliferate, shutting down other genes that keep cancer in check, Reuters reports.